StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Bionano Genomics's profit margin for the twelve months ending Jun 30, 2026 was -106.6%. For fiscal 2025 it was -92.6%, against -364.0% the year before. The highest annual figure on record is -92.6% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-92.6%+271.4
FY2024Dec 31, 2024-364.0%+279.8
FY2023Dec 31, 2023-643.7%−166.8
FY2022Dec 31, 2022-476.9%−74.1
FY2021Dec 31, 2021-402.8%+80.6
FY2020Dec 31, 2020-483.4%−189.1
FY2019Dec 31, 2019-294.3%−140.2
FY2018Dec 31, 2018-154.1%+91.7
FY2017Dec 31, 2017-245.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-90.8%+11.0
Q1 FY2026Mar 31, 2026-124.2%−76.1
Q4 FY2025Dec 31, 2025-99.8%+146.8
Q3 FY2025Sep 30, 2025-115.4%+613.1
Q2 FY2025Jun 30, 2025-101.8%+106.9
Q1 FY2025Mar 31, 2025-48.0%+310.3
Q4 FY2024Dec 31, 2024-246.5%+162.9
Q3 FY2024Sep 30, 2024-728.6%+479.5
Q2 FY2024Jun 30, 2024-208.8%+240.5
Q1 FY2024Mar 31, 2024-358.3%+142.3
Q4 FY2023Dec 31, 2023-409.4%+61.4
Q3 FY2023Sep 30, 2023-1208.0%−767.5
Q2 FY2023Jun 30, 2023-449.2%+32.9
Q1 FY2023Mar 31, 2023-500.7%+25.2
Q4 FY2022Dec 31, 2022-470.8%−106.7
Q3 FY2022Sep 30, 2022-440.5%+5.3
Q2 FY2022Jun 30, 2022-482.1%+5.1
Q1 FY2022Mar 31, 2022-525.8%−211.9
Q4 FY2021Dec 31, 2021-364.2%−70.2
Q3 FY2021Sep 30, 2021-445.8%+45.6
Q2 FY2021Jun 30, 2021-487.2%+195.9
Q1 FY2021Mar 31, 2021-314.0%+611.2
Q4 FY2020Dec 31, 2020-294.0%−10.7
Q3 FY2020Sep 30, 2020-491.4%−298.3
Q2 FY2020Jun 30, 2020-683.1%−330.7
Q1 FY2020Mar 31, 2020-925.2%−501.4
Q4 FY2019Dec 31, 2019-283.2%−123.5
Q3 FY2019Sep 30, 2019-193.1%−19.0
Q2 FY2019Jun 30, 2019-352.4%−254.7
Q1 FY2019Mar 31, 2019-423.7%−206.2
Q4 FY2018Dec 31, 2018-159.7%−367.8
Q3 FY2018Sep 30, 2018-174.1%−359.5
Q2 FY2018Jun 30, 2018-97.7%−401.6
Q1 FY2018Mar 31, 2018-217.6%−548.0
Q4 FY2017Dec 31, 2017208.1%–
Q3 FY2017Sep 30, 2017185.4%–
Q2 FY2017Jun 30, 2017303.9%–
Q1 FY2017Mar 31, 2017330.4%–

More Bionano Genomics figures

See a number that looks wrong?